Former Board Chair of Iveric Bio, Dr. Graves brings decades of experience in clinical development and strategic leadership within the ophthalmology sector. He ...
In an interview with Ophthalmology Times, Alon Kahana, MD, PhD, discusses interleukin-6 and its role in autoimmune diseases, particularly thyroid eye disease, noting that a promising alternative under ...
Fellow surgeon Dr. Michael DeSalvo says most of the diagnosed forms of thyroid cancers are now treatable with surgery, even when they spread in the neck. The most commonly diagnosed form in women is ...
Shares of Acelyrin tumbled after the company said it would stop developing its eye-disease treatment following results from a recent study. The stock fell 16%, to $3.39, in after-hours trading Tuesday ...